Grade My Investments
HomeFree Stock Grades › INGN

Inogen, Inc. (INGN) Stock Grade

INGN · Healthcare

A+
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$182.6M
P/E Ratio
Revenue Growth (YoY)
+3.9%
Net Margin
-6.5%
Return on Equity
Dividend Yield
None

About Inogen, Inc.'s fundamentals

Inogen is a small-cap medical device company with a market capitalization of $182.6 million and modest revenue growth of 3.9% year-over-year. However, the company is currently unprofitable, operating with a negative net margin of -6.5% and reporting a net loss in its latest annual statement. The company does not pay a dividend, and traditional valuation metrics like P/E ratio and return on equity are not applicable due to its loss-making status.

Track INGN free — no credit card required. Live grade + monthly AI report →